|
USA National Cancer Institute (NCI)
DHHS, NIH News
National Institute of Allergy and Infectious Diseases (NIAID)
---
FOR IMMEDIATE RELEASE
Monday, February 6, 2006
Subscribe
CONTACT:
Kathy Stover
301-402-1663
NIAID Announces Senior Management Appointments
The National Institute of Allergy and Infectious Diseases (NIAID),
part of the National Institutes of Health (NIH), recently announced
the appointment of five individuals to senior management positions
within NIAID.
Hugh Auchincloss, Jr., M.D., has been named Principal Deputy Director
of NIAID. In that capacity, he will serve as second in command to
NIAID Director Anthony S. Fauci, M.D., and will have broad
responsibilities for carrying out the Institutes many programs.
Dr. Auchincloss brings a wealth of scientific expertise and knowledge
to his new position, says Dr. Fauci. His experience and leadership
abilities will make him a great asset to our Institute in furthering
our important medical research efforts.
Prior to his appointment at NIAID, Dr. Auchincloss was Professor of
Surgery at Harvard Medical School where he earned an international
reputation in the field of organ transplantation. For more than 17
years, he operated a laboratory in transplantation immunology at
Massachusetts General Hospital in Boston with multiple research
interests, including the mechanisms and control of tissue graft
rejection, the mechanisms of transplantation tolerance induction, the
use of pancreas and islet transplantation for the treatment of
diabetes, and the prevention of recurrent autoimmunity.
In 1998, he founded the Juvenile Diabetes Research Foundation Center
for Islet Transplantation and served as its director until 2003. Most
recently, he served as Chief Operating Officer of the Immune Tolerance
Network, an NIAID-directed international consortium of clinical
researchers dedicated to developing approaches to induce immune
tolerance, a process where the immune system is selectively adjusted
by suppressing harmful immune responses and keeping protective
responses intact. The goal of the research approach is to increase the
number of successful transplants and treatments for autoimmune
diseases that attack the bodys own cells, such as type 1 diabetes,
lupus and arthritis.
Dr. Auchincloss also serves as the chairman of the Food and Drug
Administration (FDA) Subcommittee on Xenotransplantation and in 2005
was elected President of the American Society of Transplantation. He
has authored numerous scientific articles and texts and serves on the
editorial boards of several major scientific publications.
In 1972, Dr. Auchincloss graduated from Yale University with bachelors
degrees in both political science and economics and a masters degree
in economics. Dr. Auchincloss received his medical degree from Harvard
Medical School in 1976.
H. Clifford Lane, M.D., has been named NIAID Deputy Director for
Clinical Research and Special Projects. Dr. Lane will continue to
serve as the NIAID Clinical Director and Director of the newly
established Division of Clinical Research. In his new position, Dr.
Lane will also function as NIAIDs liaison with the Departments of
Defense and Homeland Security.
John J. McGowan, Ph.D., has been appointed to the new position of
NIAID Deputy Director for Science Management. He will have overall
responsibility for directing NIAIDs business and administrative
requirements as well as its science planning, policy and integration.
A virologist by training, Dr. McGowan has served in multiple roles at
NIAID including Chief of the Developmental Therapeutics Branch and
Associate Director for the Basic Research and Development Program,
both within the Institutes Division of AIDS. Most recently, Dr.
McGowan served as Director of the Division of Extramural Activities, a
position he held since 1991, and as the acting NIAID Associate
Director for Management and Operations since December 2004.
Kathryn Zoon, Ph.D., has been appointed Director of the Institutes
Division of Intramural Research (DIR) -- a position that she has
performed in an acting capacity since June 2005. Dr. Zoon previously
was Deputy Director for Planning and Development at DIR and prior to
that, she served as the Principal Deputy Director of the Center for
Cancer Research at the National Cancer Institute. Before arriving at
NIH, Dr. Zoon led the FDAs Center for Biologics Evaluation and
Research, which, during her tenure, licensed hundreds of biological
products, including vaccines. In addition to serving as associate
editor of the Journal of Interferon Research, Dr. Zoon also serves on
the board of directors of the International Association for
Biologicals. The recipient of numerous awards, Dr. Zoon was named to
the Institute of Medicine in 2002. She earned her doctorate degree
from Johns Hopkins University.
Gregory K. Folkers has been appointed Chief of Staff to Dr. Fauci,
leading the newly created Immediate Office of the Director. Mr.
Folkers came to NIAID in 1991 after being employed in various writing
and communications positions in the Boston area. After working as a
science writer and editor in the NIAID Office of Communications, he
has for the past decade worked directly with Dr. Fauci as a special
assistant and senior public affairs advisor. A graduate of Dartmouth
College, Mr. Folkers holds a masters degree in public health from
Johns Hopkins University and a masters degree in science journalism
from Boston University.
News releases, fact sheets and other NIAID-related materials are
available on the NIAID Web site at www.niaid.nih.gov.
NIAID is a component of the National Institutes of Health, an agency
of the U.S. Department of Health and Human Services. NIAID supports
basic and applied research to prevent, diagnose and treat infectious
diseases such as HIV/AIDS and other sexually transmitted infections,
influenza, tuberculosis, malaria and illness from potential agents of
bioterrorism. NIAID also supports research on transplantation and
immune-related illnesses, including autoimmune disorders, asthma and
allergies.
The National Institutes of Health (NIH) -- The Nation's Medical
Research Agency -- includes 27 Institutes and Centers and is a
component of the U. S. Department of Health and Human Services. It is
the primary Federal agency for conducting and supporting basic,
clinical, and translational medical research, and it investigates the
causes, treatments, and cures for both common and rare diseases. For
more information about NIH and its programs, visit www.nih.gov.
---
|
|
 |
